Phytopharm Share Discussion Threads

[moneymunch] 04/10/2012 21:25

but most of all, we're waiting on phase 1 clinical trial results from Summit's blockbuster potential DMD programme....positive results will truly be transformational!!! :-)))

[haroldthegreat] 27/9/2012 16:39

henderson upped their stake by 10% what do they know that we dont?????

[haroldthegreat] 27/9/2012 16:37

why the price rise? any trials due to report?

[mrsapeslaptop] 26/9/2012 15:56

looking at the shareholders.

90% of the company is held by just 30 parties. lets see what unfolds

[cestnous] 19/9/2012 15:27

Unusual nature of the recent climb makes me think you may be right A

[aishah] 19/9/2012 12:16

The rise of late - no smoke without fire imo. PIs always last to know

[cestnous] 19/9/2012 11:48

That big late trade looks like they paid a premium over the offer.

[zed250] 14/9/2012 16:02

more like 40p a share on fundamentals

[liberatingsteptoe] 14/9/2012 10:43

enigma,
That was the day that I bought in..... Guess who didn't sell.....but I did subscribe to the rights and it is nice to be back in profit, should I sell.
Things seem to be thought to be going on, so I will be waiting for the fat Lady to sing......
LS

[mrsapeslaptop] 31/8/2012 15:19

I remember shorting it when it was 5 quid. that would be nicer

[enigma2002] 31/8/2012 12:52

who remembers that spike to 30p odd a few years back :-) be nice to do that again and stay there this time.

[cestnous] 31/8/2012 12:49

Highest it's been since early 2010.

[mrsapeslaptop] 30/8/2012 12:56

Extract

Pipeline Moving Forward: As part of its restructuring program, Biogen is focusing on the
development of those candidates that represent higher return potential. In connection with this, thecompany has terminated the development of cardiovascular and oncology products. Biogen terminated 17 programs. Biogen s aim is to launch five new products by 2015. The company's main
R&D focus will be on neurological diseases like multiple sclerosis, amyotrophic lateral sclerosis(ALS), or Lou Gehrig s disease, and Parkinson s disease.



so lets wait & see. 2 years wait so far, another 5 months wont hurt :)

[bla1se] 30/8/2012 09:46

algernon2, thanks for the reply! And fingers crossed ;-)

[algernon2] 29/8/2012 20:01

bla1se:
Ignore them as to all intents and purposes they are irrelevant to us.
They are really just a short "time out" when stock shoots up or down in a frenzied manner in a short period of time.
Think of it as being a bit like a temporary traffic calming measure and that not too far from the truth.
===
May be interesting news coming I hope.

[bla1se] 29/8/2012 16:28

Anyone know the meaning of the two RNS released by the LSE on Phytopharm today?

[mrsapeslaptop] 29/8/2012 15:24

oh well. better wait to see what the news is. relatively little stock in PI hands, and the institutions seem committed to support til Parkinson's news is out.

hopefully we will gap above 12p when we find what is causing the movement.

[cestnous] 29/8/2012 15:12

Holding from a while ago. Something must be on the cards.

[mrsapeslaptop] 29/8/2012 12:58

GSK or Biogen. any other partner suggestions for ALS ?

[mrsapeslaptop] 29/8/2012 11:45

I've found this from August 8th. Suggests that ALS clinical trials can be smaller and faster (therefore cheaper).



this should increase the attractiveness of licencing cogane for ALS. Im hoping that is the next news. fingers crossed

[aishah] 29/8/2012 11:43

gaining nice momentum now....

[guidfarr] 27/8/2012 14:43

Phytopharm mentioned in September edition of spread betting magazine